Catalyst Wire Dossier Catalyst Wire Dossier

RHA4

Resilient Hyaluronic Acid dermal filler · Teoxane SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RHA4, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: RHA®4 for Midface Volume Deficiency

See pricing